Invention Grant
- Patent Title: Antigen binding molecules that bind LIGHT
-
Application No.: US16256688Application Date: 2019-01-24
-
Publication No.: US11312781B2Publication Date: 2022-04-26
- Inventor: Steve Holmes
- Applicant: Capella Bioscience Ltd.
- Applicant Address: GB London
- Assignee: Capella Bioscience Ltd.
- Current Assignee: Capella Bioscience Ltd.
- Current Assignee Address: GB London
- Agency: Morgan, Lewis & Bockius LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/00
Abstract:
The present invention relates to antigen binding molecules, including antibodies, fragments, and variants thereof, that bind to the TNF-related cytokine LIGHT (TNFSF14). The present invention also relates to methods of use of such antigen binding molecules in treating and/or preventing inflammatory disorders and immune disorders.
Public/Granted literature
- US20190315876A1 Antigen Binding Molecules That Bind LIGHT Public/Granted day:2019-10-17
Information query
